HHS Stock Analysis: Buy, Sell, or Hold?
$2.81
0.30 (11.95%)
▲
5d:
+24.34%
30d:
+13.08%
90d:
+1.44%
WAIT
LOW Confidence
Analysis Updated: Aug 13, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When HHS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: HHS is 12.0% above its trading range ($2.51). Market expects 1.0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: HHS is 12.0% above its trading range ($2.51). Market expects 1.0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$3.75
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$2.33
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 2.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HHS is currently trading at $2.81, which is considered extended relative to its 30-day fair value range of $2.20 to $2.51. The stock's valuation (Forward PE: 2.6) is in line with its historical norms (2.5). At these levels, the market is pricing in 1.0% annual earnings growth.
Technical Outlook: Technically, HHS is in a downtrend. Immediate support is located at $2.00, while resistance sits at $2.98. The stock is showing strong short-term momentum, up 12.0% recently.
Market Sentiment: HHS scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.50 (+522.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HHS is in a downtrend. Immediate support is located at $2.00, while resistance sits at $2.98. The stock is showing strong short-term momentum, up 12.0% recently.
Market Sentiment: HHS scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.50 (+522.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.20 -
$2.51
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
27.1%
All Signals
- BEARISH: Price significantly overextended (+12.0% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+12.0%)
- BULLISH: Trading 522.8% below Wall St target ($17.50)
- BULLISH: Expecting earnings turnaround to 1.0% growth with -10.3% revenue growth
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.20 -
$2.51
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.00
Resistance Level
$2.98
Current Trend
Downtrend
Technical data as of
Aug 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.63
Wall Street Target
$17.50
(+522.8%)
Revenue Growth (YoY)
-10.3%
Earnings Growth (YoY)
-90.3%
Profit Margin
-0.7%
Valuation Premium vs History
+1.0% premium
PE vs Historical
2.6 vs 2.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.0%
(market-implied from PE analysis)
1-Year Target
$2.84
(+1%)
2-Year Target
$2.87
(+2%)
3-Year Target
$2.90
(+3%)
3-Yr Target (if PE normalizes)
(PE: 3→3)
PE COMPRESSION
$2.76
(-2%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: August 14, 2026 2:09 AM ET
Data refreshes hourly during market hours. Next update: 3:09 AM
Data refreshes hourly during market hours. Next update: 3:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HHS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Conglomerates Stocks
Top-rated stocks in Conglomerates by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HON
Honeywell International … |
BUY
26 analysts |
$263 | 43 HOLD |
|
MMM
3M Company |
BUY
19 analysts |
$182 | 39 SELL |
|
BBU
Brookfield Business Part… |
STRONG BUY
6 analysts |
$41 | 52 HOLD |
|
VMI
Valmont Industries Inc |
STRONG BUY
5 analysts |
$625 | 57 HOLD |
|
PAM
Pampa Energia SA ADR |
BUY
8 analysts |
$120 | 37 SELL |